Stock Events

Stock Events

Corvus Pharmaceuticals (C17.F) Q2 2025 Earnings

8MayConfirmed

Q2 2024

Q3 2024

Q4 2024

Q2 2025

-0.57

-0.4

-0.23

-0.06

Details

Expected EPS

-0.10689239999999998

Actual EPS

-0.1158001

Surprise EPS

-0.01

Surprise Percent

+8.33%

Description

Corvus Pharmaceuticals (C17.F) has reported earnings of -0.1158001 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.